Benchmark Holdings plc (31B.F)
- Previous Close
0.4720 - Open
0.4720 - Bid 0.4820 x --
- Ask 0.5250 x --
- Day's Range
0.4720 - 0.4820 - 52 Week Range
0.3520 - 0.5250 - Volume
400 - Avg. Volume
0 - Market Cap (intraday)
381.251M - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, Vietnam, Iceland, the Faroe Islands, China, Ecuador, India, Canada, Greece, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was incorporated in 2000 and is headquartered in Sheffield, the United Kingdom.
www.benchmarkplc.com823
Full Time Employees
September 30
Fiscal Year Ends
Sector
Recent News: 31B.F
Performance Overview: 31B.F
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 31B.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 31B.F
Valuation Measures
Market Cap
373.34M
Enterprise Value
460.36M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.92
Price/Book (mrq)
1.15
Enterprise Value/Revenue
2.96
Enterprise Value/EBITDA
16.44
Financial Highlights
Profitability and Income Statement
Profit Margin
-18.96%
Return on Assets (ttm)
-0.79%
Return on Equity (ttm)
-8.05%
Revenue (ttm)
155.53M
Net Income Avi to Common (ttm)
-24.44M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
24.16M
Total Debt/Equity (mrq)
36.96%
Levered Free Cash Flow (ttm)
11.19M